Abstract
Chronic Kidney Disease (CKD) is an important public health problem throughout the world. The effects of exercise training are unclear in patients with CKD. This review aimed to evaluate the effects of exercise training to delay the progression of CKD and which training style is most effective. We developed individualized search strategies for the National Library of Medicine including the PubMed MeSH database to June 2015. We searched articles related to exercise training and kidney disease using the terms “CKD”, “renal disease”, “renal insufficiency”, “renal failure”, “end-stage renal disease (ESRD)” and “physical therapy”. We searched only for reports in English and for full free papers. We also chose papers based on the references in the papers obtained by the search. Our search identified 6 different trials including 131 participants. Our review of these 6 studies suggests that aerobic exercise training may improve exercise capacity, and resistance training may also improve muscle function in patients with CKD. No cardiac events were reported in any of the published exercise training studies reviewed, suggesting the safety of exercise in patients with CKD.
Keywords: Aerobic, chronic kidney disease, exercise, progression, renal dysfunction, resistance, training.
Reviews on Recent Clinical Trials
Title:Effects of Exercise Training on Delaying Disease Progression in Patients with Chronic Kidney Disease: a Review of the Literature
Volume: 11 Issue: 4
Author(s): Atsushi Izumi, Masahiro Kitamura and Kazuhiro P. Izawa
Affiliation:
Keywords: Aerobic, chronic kidney disease, exercise, progression, renal dysfunction, resistance, training.
Abstract: Chronic Kidney Disease (CKD) is an important public health problem throughout the world. The effects of exercise training are unclear in patients with CKD. This review aimed to evaluate the effects of exercise training to delay the progression of CKD and which training style is most effective. We developed individualized search strategies for the National Library of Medicine including the PubMed MeSH database to June 2015. We searched articles related to exercise training and kidney disease using the terms “CKD”, “renal disease”, “renal insufficiency”, “renal failure”, “end-stage renal disease (ESRD)” and “physical therapy”. We searched only for reports in English and for full free papers. We also chose papers based on the references in the papers obtained by the search. Our search identified 6 different trials including 131 participants. Our review of these 6 studies suggests that aerobic exercise training may improve exercise capacity, and resistance training may also improve muscle function in patients with CKD. No cardiac events were reported in any of the published exercise training studies reviewed, suggesting the safety of exercise in patients with CKD.
Export Options
About this article
Cite this article as:
Izumi Atsushi, Kitamura Masahiro and Izawa P. Kazuhiro, Effects of Exercise Training on Delaying Disease Progression in Patients with Chronic Kidney Disease: a Review of the Literature, Reviews on Recent Clinical Trials 2016; 11 (4) . https://dx.doi.org/10.2174/1574887111666160724182015
DOI https://dx.doi.org/10.2174/1574887111666160724182015 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Omega-3 Fatty Acids: Role in Metabolism and Cardiovascular Disease
Current Pharmaceutical Design Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs as Cyclooxygenase Inhibitors: State of the Art, Barriers and Perspectives
Current Computer-Aided Drug Design Predicting Esophageal Varices in Cirrhotic Hepatitis C Virus Patients Using Noninvasive Measurement of Insulin Resistance Variables
Endocrine, Metabolic & Immune Disorders - Drug Targets Progress and Issues of the Genome-Wide Association Study for Hypertension
Current Medicinal Chemistry One-pot α-arylation of β-carboline with Indole and Naphthol Derivatives
Current Organic Synthesis Bier Spots - Report of Two Cases and Review of the Literature
Current Rheumatology Reviews Parathyroid Hormone and Heart Failure: Novel Biomarker Strategy
Endocrine, Metabolic & Immune Disorders - Drug Targets Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy
Current Drug Targets Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Meet Our Associate Editor:
Cardiovascular & Hematological Disorders-Drug Targets Use of Peripheral Blood Stem Cells in Tissue Engineering
Current Tissue Engineering (Discontinued) Insulin and the Brain
Current Diabetes Reviews Hemodynamic Regulation of Metallopeptidases within the Vasculature
Protein & Peptide Letters The Potential Role of Morus Alba Leaves Extract on the Brain of Mice Infected with Schistosoma Mansoni
CNS & Neurological Disorders - Drug Targets Acute Phase Proteins In Atherosclerosis (Acute Coronary Syndrome)
Cardiovascular & Hematological Agents in Medicinal Chemistry Safety and Efficacy of Adenovirus Carrying Hepatocyte Growth Factor Gene by Percutaneous Endocardial Injection for Treating Post-infarct Heart Failure: A Phase IIa Clinical Trial
Current Gene Therapy Crocin Protects Against Beta-Amyloid Peptide-Induced Apoptosis in PC12 Cells Via the PI3 K Pathway
Current Molecular Pharmacology Impact of Cardiovascular Factors on Pulse Wave Velocity and Total Vascular Resistance in Different Age Group Patients with Cardiovascular Disorders
Current Aging Science Highly Resolution of Propranolol Using Oxidized Multi-walled Carbon Nanotubes and β-cyclodextrin Derivatives as Impregnating Reagents
Current Nanoscience Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque.
Current Molecular Medicine